Angiotensin receptor antagonists lower cancer risk?

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1345, 2011-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is the angiotensin receptor blocker cancer risk overstated?

Reactions Weekly, Vol. 1, Iss. 1351, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Long-term anticoagulation reduces cancer risk?

Inpharma, Vol. 1, Iss. 1245, 2000-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Tibolone associated with increased endometrial cancer risk?

Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Immunosuppressants increase post-transplant cancer risk?

Inpharma, Vol. 1, Iss. 1570, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Can Angiotensin Receptor Antagonists Be Used Safely in Patients with Previous ACE Inhibitor-Induced Angioedema?

By Howes L.G.

Drug Safety, Vol. 25, Iss. 2, 2002-01 ,pp. : 73-76

Adis International

Access to resources Recommend Favorite